
Major advances in pancreatic cancer vaccine trials
San Diego: A pancreatic cancer vaccine administered to patients three years ago continues to protect patients from cancer recurrence, a new study suggests. At a meeting of the American Association for Cancer Research in San Diego, researchers reported that eight patients who received the vaccine had no recurrence of the cancer three years later. According…